Atrás
Rango del Día
$8.69
$9.23
Rango de 52 Semanas
$3.87
$11.43
Volumen
1,664,670
Promedio 50D / 200D
$10.16
/
$6.87
Cierre Anterior
$8.84
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.8 | 0.3 |
| P/B | 1.0 | 2.9 |
| ROE % | -41.9 | 3.7 |
| Net Margin % | -122.1 | 3.8 |
| Rev Growth 5Y % | 17.6 | 10.0 |
| D/E | 0.4 | 0.2 |
Precio Objetivo de Analistas
Hold
$11.00
+20.7%
Low: $10.00
High: $12.00
P/E Futuro
25.7
EPS Futuro
$0.34
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
850 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.46
$0.45 – $0.46
|
870 M | 1 |
| FY2029 |
$0.47
$0.46 – $0.47
|
890 M | 1 |
| FY2028 |
$0.43
$0.40 – $0.45
|
870 M | 2 |
Puntos Clave
Revenue grew 17.56% annually over 5 years — strong growth
Debt/Equity of 0.44 — conservative balance sheet
Negative free cash flow of -46.35M
Revenue growth is decelerating — 1Y growth trails 5Y average by 20.76%
ROIC of 0.24% — low return on invested capital
Interest coverage of 0.13× — tight debt servicing
Crecimiento
Revenue Growth (5Y)
17.56%
Revenue (1Y)-3.20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-41.88%
ROIC0.24%
Net Margin-122.06%
Op. Margin1.05%
Seguridad
Debt / Equity
0.44
Current Ratio3.32
Interest Coverage0.13
Valoración
P/E Ratio
-1.81
P/B Ratio0.96
EV/EBITDA293.55
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.20% | Revenue Growth (3Y) | 4.30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 17.56% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 894.66M | Net Income (TTM) | -1.09B |
| ROE | -41.88% | ROA | -31.71% |
| Gross Margin | 47.10% | Operating Margin | 1.05% |
| Net Margin | -122.06% | Free Cash Flow (TTM) | -46.35M |
| ROIC | 0.24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.44 | Current Ratio | 3.32 |
| Interest Coverage | 0.13 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -1.81 | P/B Ratio | 0.96 |
| P/S Ratio | 2.21 | PEG Ratio | 0.00 |
| EV/EBITDA | 293.55 | Dividend Yield | 0.00% |
| Market Cap | 1.98B | Enterprise Value | 2.77B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 894.66M | 924.22M | 822.45M | 527.16M | 468.46M |
| Net Income | -1.09B | -9.42M | -22.87M | 48.31M | 60.88M |
| EPS (Diluted) | -5.03 | -0.04 | -0.12 | 0.45 | 0.57 |
| Gross Profit | 421.38M | 462.64M | 405.96M | 243.01M | 215.06M |
| Operating Income | 9.42M | 77.43M | 37.52M | 58.62M | 74.17M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.44B | 4.55B | 4.55B | 992.93M | 920.19M |
| Total Liabilities | 1.37B | 1.40B | 1.42B | 105.56M | 79.82M |
| Shareholders' Equity | 2.07B | 3.14B | 3.13B | 887.37M | 840.38M |
| Total Debt | 912.61M | 906.24M | 897.53M | 0.0 | 1.29M |
| Cash & Equivalents | 129.00M | 170.61M | 163.24M | 44.47M | 75.60M |
| Current Assets | 576.94M | 589.23M | 585.93M | 626.80M | 591.45M |
| Current Liabilities | 174.01M | 154.32M | 145.47M | 77.84M | 53.60M |